The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, efficacy, and outcomes of 90-yttrium radioembolization in combination with immune checkpoint inhibitors as a definitive first-line treatment approach in non-surgical hepatocellular carcinoma.
 
Alexandre Grahovac
No Relationships to Disclose
 
Tyler Sandow
No Relationships to Disclose
 
Jonathan Mizrahi
Honoraria - AstraZeneca; Exelixis
Consulting or Advisory Role - Amgen; Daichii Sankyo; Exelixis; Seagen
Speakers' Bureau - AstraZeneca; Bristol Myers Squibb Foundation; Exelixis
 
Lingling Du
Honoraria - AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Exelixis; Merus; Pfizer
Consulting or Advisory Role - American Physician Institute; AstraZeneca; Boston Scientific; Bristol-Myers Squibb; Exelixis; Merus; Pfizer
Speakers' Bureau - American Physician Institute; Zpsen
Research Funding - Boston Scientific (Inst); Compass Oncology (Inst); Pfizer (Inst); ZGM (Inst)
 
Ricardo Vallejo-Calzada
No Relationships to Disclose
 
Juan Gimenez
No Relationships to Disclose
 
Ari Cohen
Honoraria - Boston Scientific
Consulting or Advisory Role - Boston Scientific
Research Funding - Boston Scientific
 
Kelley Nunez
Research Funding - Boston Scientific
 
Paul Thevenot
Research Funding - Boston Scientific; FUJIFILM Healthcare Americas